Oncotelic Therapeutics, Inc. (OTLC) stock
OTLCOTCPharmaceutical PreparationsFiscal year ends December 31
$0.02+0.00 (+11.45%)
Close on Oct 19, 2026Market cap $8.66MP/E 0.0Yield –
Oncotelic Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Oncotelic Therapeutics's enterprise value was $7.15M on Oct 19, 2026, against $41.33M a year earlier. Over the last 5 years it ranged from $7.15M to $93.82M, with a median of $19.09M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $7.15M | -78.8% |
| 2025 | Dec 31, 2025 | $33.73M | +114.0% |
| 2024 | Dec 31, 2024 | $15.77M | -5.4% |
| 2023 | Dec 29, 2023 | $16.66M | -12.8% |
| 2022 | Dec 30, 2022 | $19.10M | -70.2% |
| 2021 | Dec 31, 2021 | $63.98M | +229.8% |
| 2020 | Dec 31, 2020 | $19.40M | +36.9% |
| 2019 | Dec 31, 2019 | $14.17M | – |
| 2018 | Dec 31, 2018 | -$455.53K | – |
| 2017 | Dec 29, 2017 | -$1.18M | – |
| 2016 | Dec 30, 2016 | -$14.54M | – |
| 2015 | Dec 31, 2015 | -$26.58M | – |
| 2014 | Dec 31, 2014 | -$26.83M | – |
| 2013 | Dec 31, 2013 | -$7.40M | – |
| 2012 | Dec 31, 2012 | -$4.70M | – |
| 2011 | Dec 30, 2011 | -$9.99M | – |
See a number that looks wrong?